Hugel

Hugel Aesthetics Breaks Into US Market with Letybo: A New Challenger for Botox
BNN
Mon, 03/4/24 - 11:50 pm
Hugel
Letybo
Botox
AbbVie
FDA
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real'
Fierce Pharma
Fri, 01/19/18 - 10:03 am
Allergan
Botox
competition
Evolus
Revance Therapeutics
Hugel